MedTech News
.................... by Andrew Celentano
Ypsomed launches YpsoLoop autoinjector platform designed for circularity
Ypsomed announced that it launched YpsoLoop, its first autoinjector platform designed for circularity.
FDA clears Mode Sensors’ fluid monitoring wearable
Mode Sensors is currently undertaking a Series A funding round to support the US market launch of its wearable sensor.
Edge Medical wins CE mark for surgical robot platform
Edge Medical announced on LinkedIn today that it received CE mark for MSP2000, its robotic-assisted “super system.”
BD Simplifies At-Home HPV Testing to Broaden Access to Cervical Cancer Screening Outside United States
FRANKLIN LAKES, N.J., Oct. 22, 2025 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a new self-collection solution for HPV testing in markets outside the United States. This new innovation simplifies at-home sample collection for patients and further automates lab processing using high-tech robotics with the BD COR™ System.
Scientists develop a way to track donor bacteria after fecal microbiota transplants
Researchers at the Icahn School of Medicine at Mount Sinai and their collaborators have developed a new technology to track beneficial bacteria after fecal microbiota transplants (FMT). The approach provides a detailed view of how donor microbes take hold and persist in the patients’ gut—not only which bacteria successfully colonized but how they change over time.
Wearable sensors and machine learning give leg up on better running data
Today’s GPS smartwatches and other wearable devices give millions of runners reams of data about their pace, location, heart rate and more. But one thing your Garmin can’t measure is plain old physics: How much force is being generated when your foot hits the ground and takes off again.
New genomic test could spare some people with melanoma from lymph node biopsy surgery
A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for cancer in their lymph nodes—a finding that could guide treatment decisions and help many people avoid lymph node biopsy surgery. The study results are published in JAMA Surgery.
Ingestible pill developed to diagnose intestinal disorder
Researchers led by investigators at Mass General Brigham and Massachusetts Institute of Technology have validated an ingestible capsule in preclinical models for the diagnosis of acute mesenteric ischemia, a condition caused by blocked or reduced blood flow to the intestines. The research is published in Science Robotics.